Falcon Point Capital’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
KFO
FAM
Falcon Point Capital's NEO Position: Q3 2020 in Review
Falcon Point Capital sold out of NeoGenomics (NEO) in Q3 2020, closing a stake of 14,412 shares — an estimated $446K sold.
Falcon Point Capital first reported a position in NEO in Q4 2014 and held it in 23 quarters. The position peaked at $14.9M in Q2 2018. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.
- Falcon Point Capital reported no remaining NeoGenomics position as of Q3 2020 after selling out during the quarter.
- Falcon Point Capital sold 14,412 NeoGenomics shares in Q3 2020, an estimated $446K.
- Falcon Point Capital first reported a position in NeoGenomics in Q4 2014 and held it in 23 quarters.
- Falcon Point Capital's NeoGenomics position peaked at $14.9M in Q2 2018.
- 294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.
Based on Falcon Point Capital's 13F filing for Q3 2020, filed 22 Oct 2020.